- Trials with a EudraCT protocol (1,494)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (67)
1,494 result(s) found for: Hepatitis A.
Displaying page 1 of 75.
EudraCT Number: 2004-005014-36 | Sponsor Protocol Number: 51/2004/U | Start Date*: 2004-04-27 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: TOLLERANZA ED EFFICACIA DELL?a-TOCOFEROLO SUCCINATO NEL TRATTAMENTO DI PAZIENTI IN ETA? PEDIATRICA AFFETTI DA EPATITE CRONICA HBsAg POSITIVA | |||||||||||||
Medical condition: Potenziamento della risposta immunitaria antivirale e riduzione del danno epatico in pazienti in eta' pediatrica affetti da epatopatia cronica HBV correlata. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002589-38 | Sponsor Protocol Number: HBV-2013 | Start Date*: 2013-07-11 | |||||||||||||||||||||
Sponsor Name:Universität Innsbruck, Institut für Biomedizinische Alternsforschung | |||||||||||||||||||||||
Full Title: Primary and booster vaccination in old age: Hepatitis A and Hepatitis B | |||||||||||||||||||||||
Medical condition: This study will analyze cellular and humoral immune reponses after primary or booster vaccination against HAV and HBV. Healthy adults will be vaccinated with a combination vaccine, which is license... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006588-21 | Sponsor Protocol Number: HLS02/2006 | Start Date*: 2007-05-10 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection | |||||||||||||
Medical condition: Chronic hepatitis C in HIV/HCV coinfection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002483-26 | Sponsor Protocol Number: 1998/2005 | Start Date*: 2005-12-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. | |||||||||||||
Medical condition: Chronic Hepatitis C with or without cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000279-40 | Sponsor Protocol Number: SF3PEG-RIBA | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:A.S.L. 2 | |||||||||||||
Full Title: Randomised phase 3B study on comparison of 2 treatment schedules with peginterferon alpha 2b and ribavirin short term versus standard term schedules in patients with chronic hepatitis C, genotype... | |||||||||||||
Medical condition: Patients with chronic hepatitis C with genotype 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002069-77 | Sponsor Protocol Number: RG101-05 | Start Date*: 2016-12-01 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101 | ||||||||||||||||||||||||||||||||||||||
Medical condition: Hepatitis C Patients | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004852-38 | Sponsor Protocol Number: MV 17149 - HELPS | Start Date*: 2005-04-06 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: A randomized, open label, multicenter, parallel group study evaluating the efficacy and safety of 135 mcg and 90 mcg of Pegasys given as monotherapy to patients with chronic hepatitis C and end-sta... | |||||||||||||
Medical condition: chronic hepatitis C CHC virus infection in patients with end-stage renal disease ESRD undergoing hemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001927-39 | Sponsor Protocol Number: ST1472-DM-03-007 | Start Date*: 2005-01-20 | |||||||||||
Sponsor Name:SIGMA-TAU | |||||||||||||
Full Title: A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY TO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALP... | |||||||||||||
Medical condition: TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003853-29 | Sponsor Protocol Number: METVIRAL | Start Date*: 2005-12-09 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïv... | |||||||||||||
Medical condition: CHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCE | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004111-37 | Sponsor Protocol Number: BHC-ABT-001 | Start Date*: 2014-10-22 | |||||||||||
Sponsor Name:BUDAI HEPATOLÓGIAI CENTRUM | |||||||||||||
Full Title: Individual Patient Access to AbbVie ABT-450/rítonavir/ABT-267 and ABT 333 Coadministered witb Ribavirín (RBV) in Patient with Genotype 1 Hepatitis C Vírus Infection witb Cirrhosis | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003649-18 | Sponsor Protocol Number: V232-059-00 | Start Date*: 2007-01-12 | |||||||||||
Sponsor Name:Merck & Co. Inc. | |||||||||||||
Full Title: A Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004394-90 | Sponsor Protocol Number: IM1 | Start Date*: 2012-01-05 | ||||||||||||||||
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie | ||||||||||||||||||
Full Title: Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1 | ||||||||||||||||||
Medical condition: Patients with CHC and liver cirrhosis who are not applicable to standard therapy due to the presence of a contraindication. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-006221-27 | Sponsor Protocol Number: 146/2007/U/Sper | Start Date*: 2008-04-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients | |||||||||||||
Medical condition: HCV cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002264-33 | Sponsor Protocol Number: AH01 | Start Date*: 2014-08-25 | |||||||||||
Sponsor Name:Ole Hamberg | |||||||||||||
Full Title: Rifaximin in alcoholic hepatitis: effects on inflammatory and metabolic markers. | |||||||||||||
Medical condition: Alcoholic hepatitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021473-36 | Sponsor Protocol Number: KB050 | Start Date*: 2011-11-22 | |||||||||||
Sponsor Name:KEDRION | |||||||||||||
Full Title: Efficacy and Safety evaluation of Kedrion Human Hepatitis B Immunoglobulin for intramuscular use in the prevention of hepatitis B in the newborns of Hepatitis B Virus carrier-mothers: multi-centr... | |||||||||||||
Medical condition: Newborns of hepatitis B virus carrier mothers | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001638-42 | Sponsor Protocol Number: 057-00 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:MSD (Norge) AS | |||||||||||||
Full Title: Study to Assess the Safety, Tolerability, and Immunogenicity of 2 Antigen Doses of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process Administered to Healthy Infants at 2, 4, and ... | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005643-26 | Sponsor Protocol Number: PrefoCir2 | Start Date*: 2012-03-15 | ||||||||||||||||
Sponsor Name:ZAMBON ITALIA | ||||||||||||||||||
Full Title: Cross-over pharmacokinetic study and pharmacodynamics of 2 different folate (5-MTHF and folic acid) in patients with liver cirrhosis with viral etiology. A randomized, open-label trial. | ||||||||||||||||||
Medical condition: In all cases of folate deficiency due to increased demand, poor absorption, inadequate dietary intake and reduced utilization of the vitamin in patients with viral liver cirrhosis. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-018361-33 | Sponsor Protocol Number: HCV689-201 | Start Date*: 2010-09-10 | ||||||||||||||||||||||||||
Sponsor Name:Arrow Therapeutics Ltd. (a member of the AstraZeneca group of companies) | ||||||||||||||||||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in P... | ||||||||||||||||||||||||||||
Medical condition: Chronic hepatitis C virus (genotype 1b) infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SK (Completed) HU (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001942-16 | Sponsor Protocol Number: GS-US-334-0133 | Start Date*: 2012-08-10 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks in Treatment-Naïve and Treatment-Experienced Su... | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: EE (Completed) AT (Completed) NL (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-001071-40 | Sponsor Protocol Number: ISM10-06 | Start Date*: 2011-08-11 | ||||||||||||||||
Sponsor Name:InSpira Medical AB | ||||||||||||||||||
Full Title: A Phase IIa Safety study of oral administration of anti-CD3 monoclonal antibody in non-responder genotype-I chronic Hepatitis C subjects, a single-blind, randomized, controlled multi-center study | ||||||||||||||||||
Medical condition: in non-responder genotype-I chronic Hepatitis C subjects | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) PL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
